4.4 Article

Rethinking chronic toxicity and carcinogenicity assessment for agrochemicals project (ReCAAP): A reporting framework to support a weight of evidence safety assessment without long-term rodent bioassays

Journal

REGULATORY TOXICOLOGY AND PHARMACOLOGY
Volume 131, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yrtph.2022.105160

Keywords

Mode of action (MoA); New approach methodology (NAM); Integrated approach to testing and assessment; (IATA); Weight of evidence (WoE); Carcinogenicity; Chronic toxicity; Hazard classification; Risk assessment; Rodent bioassay; Reporting framework

Ask authors/readers for more resources

Rodent cancer bioassays have long been required for assessing human cancer hazard and risk, but new technologies have emerged in the past decade that can effectively evaluate these factors while reducing animal use. To facilitate the adoption of these technologies, a group of scientists developed a framework for waiver rationales for rodent cancer bioassays in agrochemical safety assessment. This framework considers various factors, such as use patterns, exposure scenarios, mode-of-action, and chemical properties, and can be applied to other chemicals and endpoints as well.
Rodent cancer bioassays have been long-required studies for regulatory assessment of human cancer hazard and risk. These studies use hundreds of animals, are resource intensive, and certain aspects of these studies have limited human relevance. The past 10 years have seen an exponential growth of new technologies with the potential to effectively evaluate human cancer hazard and risk while reducing, refining, or replacing animal use. To streamline and facilitate uptake of new technologies, a workgroup comprised of scientists from government, academia, non-governmental organizations, and industry stakeholders developed a framework for waiver rationales of rodent cancer bioassays for consideration in agrochemical safety assessment. The workgroup used an iterative approach, incorporating regulatory agency feedback, and identifying critical information to be considered in a risk assessment-based weight of evidence determination of the need for rodent cancer bioassays. The reporting framework described herein was developed to support a chronic toxicity and carcinogenicity study waiver rationale, which includes information on use pattern(s), exposure scenario(s), pesticidal mode-of-action, physicochemical properties, metabolism, toxicokinetics, toxicological data including mechanistic data, and chemical read-across from similar registered pesticides. The framework could also be applied to endpoints other than chronic toxicity and carcinogenicity, and for chemicals other than agrochemicals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available